Learn

Fertility Genetics

Where genetic counseling fits into fertility care: genetic causes of infertility, what PGT can and cannot tell you, mosaic embryo results, and donor screening.

Genetics can play a role at several points in a fertility journey, from understanding an underlying cause of infertility to deciding which embryos to transfer during IVF. This page covers where genetic counseling fits into fertility care rather than the full IVF process, which your fertility clinic is best positioned to walk you through.

Would you like to meet with a genetic counselor?Schedule an Appointment

Fertility Evaluation: Genetic Causes of Infertility

Genetic factors can contribute to infertility, in both male and female partners. In women, this can include chromosomal differences or conditions affecting ovarian reserve or function. In men, it can include chromosomal differences or gene changes affecting sperm production. Identifying a genetic cause doesn't always change the immediate treatment plan, but it can inform decisions about testing options and, in some cases, the risk of passing a condition to a future child.

Genetic counseling can help determine whether testing may be useful based on your medical history, family history, fertility evaluation, and reproductive goals. Testing is most likely to be helpful when there is absent or very low sperm production (azoospermia or oligospermia), premature ovarian insufficiency, recurrent pregnancy loss, repeated unsuccessful embryo transfers, a known chromosome rearrangement, certain medical or physical findings, or a personal or family history of a genetic condition.

If a genetic explanation for infertility is found, this information may guide your treatment plan. A genetic counselor will help you understand how a diagnosis may affect the person tested, if a condition could be passed to a child, testing options and next steps.

Unexplained Infertility

A 2026 review puts the figure at roughly a third of couples experiencing infertility being given a diagnosis of unexplained infertility1, meaning standard testing hasn't identified a clear cause. This label can be frustrating, but it doesn't necessarily mean there's no explanation, only that one hasn't been found through routine workup. In some cases, more targeted genetic testing can identify a contributing factor that wasn't captured by standard fertility testing.

Genetic Counseling Before Assisted Reproductive Technologies (ART)

A genetic counselor reviews your personal and family medical history (up to three generations), creating a detailed family tree (pedigree), identifying inherited conditions, chromosome differences, or patterns that may affect your health, fertility care, pregnancy, or a future child. Common genetic conditions that may affect fertility are: Klinefelter syndrome, Turner syndrome, Y-microdeletions, Fragile X premutation, balanced chromosome translocations, and cystic fibrosis.

A pre-IVF consultation can help you understand whether carrier screening, chromosome testing, testing for a known familial condition, or preimplantation genetic testing (PGT) may be relevant. It can also clarify what each test can and cannot tell you, review possible results before a cycle begins, and discuss how results could affect embryo-testing, donor selection, pregnancy testing, or future medical care. Because you are being intentional about growing your family, having these conversations early gives you time to consider your options and align them with your values, timeline, and treatment goals.

Male infertility and ICSI

Male factors are involved in about half of infertility cases2. A 2025 review estimates that genetic changes may affect the quantity and quality of sperm, explaining at least a third of male infertility3.

Intracytoplasmic sperm injection (ICSI) is a technique used during IVF in which a single sperm is injected directly into an egg, rather than relying on natural fertilization in a dish. It's often used in cases of male factor infertility, but is also used for other clinical reasons your fertility team may discuss with you.

In their male infertility guideline, updated in 2024, the AUA and ASRM recommend that genetic testing be offered to patients with some types of azoospermia (no sperm found in the semen analysis) or very low sperm counts (oligospermia). A genetic counselor can help explain genetic results (like karyotype, microarray, microdeletions, or CFTR testing) and inform patients if male genetic changes could affect their children's health4.

PGT Overview

Preimplantation genetic testing (PGT) is a complex process that includes in vitro fertilization (IVF/ICSI), embryo biopsy, embryo freezing, genetic analysis and embryo selection for transfer. It was previously known as preimplantation genetic diagnosis (PGD) or preimplantation genetic screening (PGS). It covers a few distinct types of testing, each answering a different question:

  • PGT-A screens embryos for the correct number of whole chromosomes. Aneuploidy (A) occurs when there are more or less than the typical number of chromosomes. An example of aneuploidy is Down syndrome, which occurs when there are three copies of chromosome 21. Because the chromosomes that determine sex are included in the testing, patients can elect to know the sex of the embryos. PGT-A can be offered for advanced maternal age, aneuploidy-related recurrent miscarriages, and infertility due to severe male factor. PGT-A doesn't test for genetic conditions caused by a single gene change, and its use for other indications is under review.
  • PGT-M tests embryos for a specific gene change associated with a monogenic disorder (M). It is indicated when a parent is affected by a specific condition or there is a risk of passing a known genetic disease to a child. Examples of monogenic conditions are: Huntington disease, thalassemia, sickle cell disease, cystic fibrosis, hereditary breast and ovarian cancer syndrome (BRCA1/2), and spinal muscular atrophy. PGT-M can also be used to identify unaffected embryos that could also be compatible donors for an affected sibling.
  • PGT-SR tests for structural chromosomal rearrangements (SR), such as a balanced translocation carried by a parent, that can affect an embryo's chromosome structure. PGT-SR is usually combined with PGT-A, so it can identify balanced/normal embryos for the chromosomal rearrangement.
  • PGT-G screens the embryo's genome (G). Genome sequencing looks for changes in the embryo's genetic instructions (DNA) that may be related to IVF failure, early pregnancy loss or serious medical conditions. Because it is an emerging technology, as of October 2026 there are no professional guidelines for PGT-G.

Some clinics and companies also offer embryo testing based on polygenic risk scores (PGT-P), which estimate the chance of common conditions rather than looking for a single gene change. In a 2026 ethics opinion, ASRM concluded that PGT-P is not ready for routine clinical use, pointing to limited evidence on its accuracy and the risk that results are misleading5. If you have been offered PGT-P, or have read about it and are weighing it, it is a reasonable thing to raise in a consult: a genetic counselor can walk you through what a polygenic score does and does not predict, and what is known so far.

A genetic counselor can help you understand which type, if any, is relevant to your situation. Remember that PGT does not detect all possible genetic conditions and transferring PGT-selected embryos does not guarantee a pregnancy, or the birth of a healthy child. They can also explain limitations of PGT technology, residual risks, genetic conditions that cannot be tested, and help you plan for next steps, including the option of prenatal testing (CVS or amniocentesis).

Understanding Mosaic PGT Results

Some PGT-A results come back as mosaic, meaning the small sample of cells tested may contain a mixture of cells with different chromosome numbers. Mosaic results don't fit neatly into a simple normal-or-abnormal framework, and their significance is still an active area of research. PGT-A is a screening test and does not examine each cell individually or test the entire embryo. Moreover, PGT laboratories also differ in how they identify and report mosaic results, making a review of your specific results important. Because there are multiple reports of healthy babies born after the transfer of mosaic embryos, you should discuss your results with your IVF clinic before deciding to discard them as abnormal. You may choose to transfer these embryos, understanding that, per ASRM's 2023 committee opinion, mosaic embryos have lower implantation and higher miscarriage rates than euploid (normal) embryos6. A genetic counselor can walk you through that decision, including the informed consent involved, and help you understand what is and isn't known about a specific mosaic finding as you and your fertility team weigh next steps.

Transferring Embryos with Abnormal PGT-A Results

PGT-A analyzes a small sample of embryo cells rather than the entire embryo, and is considered a screening test. Results reported as abnormal (aneuploid, segmental aneuploidy, etc.) are different from mosaic results: depending on the specific finding, transfer may carry a high chance of unsuccessful implantation or miscarriage and may result in a child with a chromosome condition. Births without the reported chromosome difference have been documented, but the evidence is limited, and the likelihood varies by the PGT-A result and/or testing laboratory. Some patients consider transferring embryos with abnormal PGT-A results because they hope for the small chance of a pregnancy without the reported chromosome difference, would consider ending a pregnancy if a chromosome condition is confirmed, or are open to parenting a child with that condition. A genetic counselor can provide nonjudgmental support, review the laboratory report and available evidence, and discuss possible pregnancy outcomes and prenatal diagnostic testing so that decisions reflect your values and reproductive goals. It is important that you discuss transfer policies with your fertility clinic.

Recurrent Implantation Failure

Recurrent implantation failure refers to multiple embryo transfers that haven't resulted in a pregnancy, despite transferring embryos that appeared to be of good quality. It has a range of possible contributing factors, some genetic and some not, and a genetic counselor can help you think through whether genetic testing, of you, a partner, or the embryos themselves, is a piece worth exploring further.

Recurrent Pregnancy Loss (RPL)

Recurrent pregnancy loss is defined as having two or more spontaneous pregnancy losses, excluding ectopic and molar pregnancies. Embryonic aneuploidy is the most common cause of sporadic and recurrent miscarriage during the first trimester. However, RPL is often multifactorial, and a genetic cause is just one of the possible explanations. Please follow this link to learn more about recurrent pregnancy loss.

Genetic Screening and Counseling for Gamete Donors and Recipients

If you're considering donor eggs or donor sperm, genetic screening is typically part of the process, and can meaningfully reduce, though not eliminate, certain genetic risks to a future child.

Following the American Society for Reproductive Medicine's (ASRM) 2024 guidance on gamete and embryo donation7, a genetic counselor can help you:

  • Understand what a donor's genetic screening results mean and what questions are worth asking your clinic or donor bank.

    Many donors are carriers of recessive conditions, which doesn't automatically rule them out. If your donor carries a recessive condition, a counselor can explain the condition, how it's inherited, how common it is, and what screening can and can't detect. The counselor can also help you understand the remaining (residual) risk, even after a negative result, before you decide whether to proceed with that donor.
  • Match your carrier screening with your donor's. Different labs test for different sets of conditions, so results aren't always directly comparable. ASRM advises that, ideally, the egg and sperm sources be screened for the same conditions. When different panels are used, a genetic counselor can review the results to determine whether additional screening is needed.
  • Understand your donor's family history. ASRM recommends that a certified genetic counselor or another qualified genetics professional review each donor's detailed three-generation family history and assess the risk of conditions that could be passed on. You can review that history with a genetic counselor. If you're working with a directed (known) donor, you should be offered the same kind of review.

No screening can guarantee that a child will be free of genetic conditions. A genetic counselor can help you weigh the remaining risks to donor-conceived children, understand your options and feel confident in your choice.

When a Fertility Clinic Refers to Genetic Counseling

Fertility clinics often refer patients to genetic counseling at specific points: after an abnormal or unexpected genetic test result, before starting PGT, after recurrent implantation failure or pregnancy loss, or when family history raises a question the clinic wants addressed directly. If your fertility clinic has suggested genetic counseling, or if you're wondering whether it might help, that's exactly the kind of question a consult can address.

It is advisable that anyone considering PGT meet with a genetic counselor, either at their IVF clinic or an independent one, for comprehensive reproductive genetics care. Genetic counselors employed by PGT laboratories work closely with IVF clinics and can explain that laboratory's test in detail, but they typically provide a more targeted service, focused on the test their employer offers rather than on your situation as a whole.

If you're exploring fertility preservation rather than active treatment, see our Fertility Preservation page.

You might consider fertility-focused genetic counseling if you're wondering:

  • My fertility clinic recommended PGT. What does it actually test for?
  • We've had a mosaic embryo result and aren't sure what it means.
  • I've been diagnosed with unexplained infertility. Could genetics be part of the picture?
  • We're considering donor eggs or sperm and want to understand the genetic screening involved.
  • I'm not sure if my situation fits, but I'd like to talk to someone about it.

What This Consult Doesn't Replace

Genetic counseling is a valuable complement to your fertility care, not a substitute for it. A genetic counseling consult does not replace your care with a reproductive endocrinologist or fertility clinic, and it doesn't determine your treatment plan. It's meant to give you and your fertility team a clearer picture of the genetic piece of your care. Genetic counseling and testing are optional, and you have the right to accept or decline services after receiving clear information8.

Ready to consult with a genetic counselor?

Whether you're just starting a fertility workup or in the middle of an IVF cycle, a genetic counselor can help you understand what your results, or your options, mean for your path forward.

Schedule an Appointment

To discuss this topic, choose the Fertility Genetics Consult appointment type when scheduling.

References

  1. Raperport C, et al. Unexplained infertility: an update. The Obstetrician & Gynaecologist 2026;28(2):100-108.
  2. Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline. American Urological Association, 2020; amended 2024.
  3. Zikopoulos A, et al. Genetic and epigenetic risks of male infertility in ART. Int J Mol Sci 2025;26(24):11812.
  4. Brannigan RE, et al. Updates to male infertility: AUA/ASRM guideline. J Urol, published online August 15, 2024.
  5. Use of preimplantation genetic testing for polygenic disorders (PGT-P): an Ethics Committee opinion. American Society for Reproductive Medicine. Fertil Steril 2026;125(1):24-30.
  6. Clinical management of mosaic results from preimplantation genetic testing for aneuploidy of blastocysts: a committee opinion. American Society for Reproductive Medicine and Genetic Counseling Professional Group. Fertil Steril 2023;120(5):973-982; erratum 2026;126(2):453.
  7. Gamete and embryo donation guidance. American Society for Reproductive Medicine and Society for Assisted Reproductive Technology. Fertil Steril 2024;122(5):799-813.
  8. Ethical considerations for genetic testing and counseling in obstetrics and gynecology. American College of Obstetricians and Gynecologists' Committee on Ethics. Obstet Gynecol 2026;147(1):e16-e23.

Last updated: October 2026